Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma-Reference-Cited by-同舟云学术

Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma

Published:2020-05 Issue:5 Volume:72 Page:896-908
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Dong Liang-qing,Peng Li-hua,Ma Li-jie,Liu Dong-bing^ORCID,Zhang Shu,Luo Shu-zhen,Rao Jun-hua,Zhu Hong-wen,Yang Shuai-xi,Xi Shui-jun,Chen Min,Xie Fan-fan,Li Fu-qiang,Li Wen-hui,Ye Chen,Lin Li-ya,Wang Yu-jue,Wang Xiao-ying,Gao Da-ming,Zhou Hu,Yang Huan-ming,Wang Jian,Zhu Shi-da,Wang Xiang-dong,Cao Ya,Zhou Jian,Fan Jia,Wu Kui^ORCID,Gao Qiang

Funder

National Natural Science Foundation of China

Basic Research Project from Technology Commission

National Science and Technology Major Project of China

Science, Technology and Innovation Commission of Shenzhen Municipality

Publisher

Elsevier BV

Subject

Hepatology

Reference44 articles.

1. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

2. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;The Lancet,2017